Herve de Kergrohen, M.D., has been named CEO and director of Anavex Life Sciences Corp., a Geneva, Switzerland, company that develops drugs for the treatment of cancer and neurological diseases. De Kergrohen for the past several years had been a partner in the life sciences division of Paris-based venture capital firm CDC Innovation. In 2007 and 2008, de Kergrohen was CEO of Praxim, which develops and sells equipment for robotic orthopedic surgery. His age was unavailable.Submit a letter to the Modern Physician Reader Blog. Please include your name, title, company and hometown. Modern Physician reserves the right to edit all submissions.
Herve de Kergrohen named CEO of Anavex Life Sciences
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.